5 tennis players to watch at the 2010 Cancer Treatment Centers of America Tennis Championships in Surprise
5 tennis players to watch at the 2010 Cancer Treatment Centers of America Tennis Championships in Surprise
5 players to watch at the 2010 Cancer Treatment Centers of America Tennis Championships in Surprise
Read more on The Arizona Republic
BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of BARACLUDE for the treatment of chronic hepatitis B (CHB) in adult patients with decompensated liver disease.
Read more on News-Medical-Net